SIBN
$12.79+0.02 (+0.16%)
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroilia...
Recent News
Jim Cramer on SI-BONE, Inc.: “We’re Not Going to Buy the Money Losers”
SI-BONE, Inc. (NASDAQ:SIBN) is one of the stocks Jim Cramer answered questions about. Inquiring about the stock, a caller mentioned that it has declined around 30% since they last asked about it in January. In response, Cramer said: Gee, I don’t know. That’s, whoa, they’re losing too much money. We’re in a tough tape. We’re […]
SI-BONE, Inc. Q4 2025 Earnings Call Summary
Moby summary of SI-BONE, Inc.'s Q4 2025 earnings call
Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio
The iFuse TORQ portfolio includes the iFuse TORQ TNT and iFuse TORQ implants.
SI-BONE Inc (SIBN) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ...
SI-BONE Inc (SIBN) reports robust revenue growth and strategic initiatives, setting the stage for continued expansion in 2026 despite anticipated challenges.
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +69.23% and +0.09%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?